Dr Gerard Criner from Temple University was the featured speaker for a presentation at ATS 2018 that focused on the cost-effectiveness of home oxygen therapy combined with home noninvasive ventilation for COPD patients in the United States.

Originally published in 2017, the HOT-HMV study showed significant clinical benefits for COPD patients in the United Kingdom using noninvasive ventilation combined with supplemental oxygen. Continued analysis by US researchers has explored the application of the UK data into an economic model for patients in the United States, where 1.1 million ED visits a year are tied to COPD.

The following presentation from Dr Criner was filmed at ATS 2018 and includes valuable analysis on how reducing COPD exacerbations and admissions can reduce associated hospital costs for US patients.